Back

Genetic Risk for Alcohol Use Disorder in Relation to Individual Symptom Criteria: Do Polygenic Indices Provide Unique Information for Understanding Severity and Heterogeneity?

Kim, Y.; Lane, S. P.; Miller, A. P.; Wilhelmsen, K. C.; Gizer, I. R.

2024-09-23 psychiatry and clinical psychology
10.1101/2024.09.20.24313762
Show abstract

Alcohol Use Disorder (AUD) is a heterogenous category with many unique configurations of symptoms. Previous investigations of AUD heterogeneity using molecular genetics methods studied the association between genetic liability and individual AUD symptoms at the latent level or focusing on a small number of genetic variants. Notably, these studies did not investigate potential severity differences between symptoms in their genetic analyses. Therefore, the current study aimed to examine the genetic risk for individual AUD symptom criteria by using a polygenic risk score (PRS) approach to assess the relative severity of each AUD symptom and test for associates with AUD symptoms above and beyond a unidimensional AUD construct. An AUD PRS was created using summary statistics obtained from published genome-wide association studies (GWAS), and Multiple Indicators Multiple Causes (MIMIC) models were employed to examine the effect of the PRS on overall AUD severity as well as on individual symptoms after accounting for this overall effect. The phenotypic severity of AUD symptoms was highly correlated with the genetic severity of AUD symptoms (r = 0.78). Results of MIMIC models indicated that the AUD PRS significantly predicted the AUD factor. Regression paths testing the unique, direct effects of the PRS on individual AUD symptoms, independent of the latent AUD factor, were not significant. These results imply that PRSs derived from GWAS of AUD influence symptom expression through a single genetic factor that is highly correlated with the relative severity of individual symptoms when measured at the phenotypic level. Item-level GWAS of AUD symptoms are needed to further parse heterogeneous symptom expression and allow for more nuanced tests of these conclusions.

Matching journals

1
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 0.6%
29× avg
2
Addiction Biology
Wiley · based on 13 published papers
#1
147× avg
3
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 0.2%
81× avg
4
American Journal of Psychiatry
American Psychiatric Association Publishing · based on 14 published papers
#1
132× avg
5
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 64%
6.1%
6
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Wiley · based on 15 published papers
#1
104× avg
7
Psychological Medicine
Cambridge University Press (CUP) · based on 52 published papers
Top 2%
15× avg
8
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 2%
16× avg
9
Biological Psychiatry
Elsevier BV · based on 36 published papers
Top 2%
12× avg
10
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 57%
2.7%
11
Biological Psychiatry Global Open Science
Elsevier BV · based on 23 published papers
Top 1%
23× avg
12
Journal of Psychiatric Research
Elsevier BV · based on 22 published papers
Top 1%
21× avg
13
Frontiers in Psychiatry
Frontiers Media SA · based on 56 published papers
Top 5%
5.1× avg
14
Journal of Affective Disorders
Elsevier BV · based on 72 published papers
Top 4%
3.8× avg
15
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
Top 2%
11× avg
16
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier BV · based on 27 published papers
Top 2%
11× avg
17
Drug and Alcohol Dependence
Elsevier BV · based on 21 published papers
Top 1%
11× avg
18
Frontiers in Genetics
Frontiers Media SA · based on 32 published papers
Top 4%
7.0× avg
19
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 4%
6.0× avg
20
Developmental Cognitive Neuroscience
Elsevier BV · based on 14 published papers
Top 0.8%
22× avg
21
European Neuropsychopharmacology
Elsevier BV · based on 11 published papers
Top 2%
13× avg
22
JAMA Psychiatry
American Medical Association (AMA) · based on 11 published papers
Top 2%
15× avg
23
Schizophrenia Bulletin
Oxford University Press (OUP) · based on 21 published papers
Top 3%
4.5× avg
24
Journal of Child Psychology and Psychiatry
Wiley · based on 18 published papers
Top 2%
8.6× avg
25
European Child & Adolescent Psychiatry
Springer Science and Business Media LLC · based on 14 published papers
Top 3%
7.4× avg